Spark Investment Management LLC Otonomy, Inc. Transaction History

Spark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$2.13 - $3.83 $28,116 - $50,556	-13,200 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.12 - $2.86 $36,042 - $48,622	-17,001 Reduced 56.29%	13,200 $31,000
Q2 2019 Aug 12, 2019	SELL	$2.35 - $3.09 $37,614 - $49,458	-16,006 Reduced 34.64%	30,201 $83,000
Q1 2019 May 07, 2019	BUY	$1.8 - $2.97 $31,033 - $51,205	17,241 Added 59.52%	46,207 $121,000
Q4 2018 Feb 12, 2019	SELL	$1.51 - $2.93 $16,812 - $32,622	-11,134 Reduced 27.77%	28,966 $53,000
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.95 $104,260 - $158,395	40,100 New	40,100 $110,000
Q4 2017 Feb 12, 2018	SELL	$2.8 - $5.55 $616,000 - $1.22 Million	-220,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$3.2 - $20.8 $704,000 - $4.58 Million	220,000	220,000 $715,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.